Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non–Squamous Non–Small Cell Lung Cancer
Ramaswamy Govindan, Mike Lind, Amelia Insa, Saad A. Khan, Dmitry Uskov, Ali Tafreshi, Salih Guclu, Jair Bar, Terufumi Kato, Ki Hyeong Lee, Kazuhiko Nakagawa, Olfred Hansen, Bonne Biesma, Madan G. Kundu, Martin Dunbar, Lei He, Peter Ansell, Vasudha Sehgal, Xin Huang, Jaimee GlasgowBruce A. Bach
Dive into the research topics of 'Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non–Squamous Non–Small Cell Lung Cancer'. Together they form a unique fingerprint.